UPDATE 1-Alexion revenue misses, forecasts 2017 profit below estimates
February 16, 2017 at 07:01 AM EST
Feb 16 (Reuters) - Alexion Pharmaceuticals Inc reported quarterly revenue that missed estimates, hurt by lower-than-expected demand for its flagship drug Soliris and forecast 2017 earnings, revenue below expectations.
